Stockreport

TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years

TScan Therapeutics, Inc.  (TCRX) 
PDF WALTHAM, Mass., Nov. 30, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T c [Read more]